PECO vs SBRA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
PECO exhibits a stable but mediocre Piotroski F-Score of 4/9, while trading at a significant premium to both its Graham Number ($19.08) and Intrinsic Value ($26.25). The most critical concern is the unsustainable dividend payout ratio of 140.81%, indicating the company is paying out more than it earns. Despite strong 5-year historical price performance and a 'Buy' analyst consensus, the combination of a bearish technical trend (10/100) and extreme valuation multiples suggests a high risk of correction.
SBRA presents a precarious financial profile with a Piotroski F-Score of 4/9, indicating only stable, non-strong health. The stock is trading at a severe premium to both its Graham Number ($12.71) and Intrinsic Value ($4.48), while maintaining a dangerous dividend payout ratio of 187.5%. Despite double-digit revenue growth, the company is experiencing a sharp contraction in earnings (-44.7% YoY), suggesting a fundamental disconnect between top-line growth and profitability. The combination of bearish technicals, negative insider sentiment, and unsustainable dividends suggests a value trap despite optimistic analyst targets.
Compare Another Pair
Related Comparisons
PECO vs SBRA: Head-to-Head Comparison
This page compares Phillips Edison & Company, Inc. (PECO) and Sabra Health Care REIT, Inc. (SBRA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.